Zydus Cadila gets USFDA nod for generic gout attacks drug

The company has received the tentative approval from the USFDA to market Colchicine tablets USP in the strength of 0.6 mg, Zydus Cadila said in a statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news